“I think there’s enthusiasm for post-acute benefit management now because people are looking for ways to significantly lower their cost of doing business while also ensuring that patients get the care they need,” says Driscoll. He wants to convince insurers that he can do it at a lower cost.
Quality improvement measures in the neonatal intensive care unit have primarily focused on babies born in the lowest gestational age (GA) ranges, but they make up 5% of premature infants born in the United States. Researchers argue that it pays to look at quality across the entire GA range.
Gary Claxton, Kaiser Family Foundation
Only 11 of the not-for-profit health plans are still operating, and the program that would cushion them from financial losses is in trouble. Will it be fixed?
Pharmaceutical companies still hold important cards when it comes to negotiating prices, but that may change with new ways of measuring value.
James Helstrom, CMO of Fox Chase Cancer Center
At last there is a treatment for the inherited condition that affects bone development. But at $300,000 per year, cost is a major issue.